Louisiana State Employees Retirement System Makes New $598,000 Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Louisiana State Employees Retirement System purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, Holdings Channel reports. The firm purchased 7,900 shares of the company’s stock, valued at approximately $598,000.

Other hedge funds have also recently modified their holdings of the company. Xponance Inc. raised its stake in shares of Henry Schein by 2.1% in the third quarter. Xponance Inc. now owns 21,839 shares of the company’s stock worth $1,622,000 after purchasing an additional 443 shares during the last quarter. Everett Harris & Co. CA raised its stake in shares of Henry Schein by 29.1% in the fourth quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock worth $7,925,000 after purchasing an additional 23,622 shares during the last quarter. Sprucegrove Investment Management Ltd. raised its stake in shares of Henry Schein by 14.2% in the fourth quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after purchasing an additional 27,500 shares during the last quarter. Caxton Associates LP raised its stake in shares of Henry Schein by 80.8% in the third quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock worth $1,410,000 after purchasing an additional 8,486 shares during the last quarter. Finally, American Century Companies Inc. raised its stake in shares of Henry Schein by 7.3% in the third quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock worth $350,392,000 after purchasing an additional 322,649 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on HSIC shares. Barrington Research boosted their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 28th. Leerink Partnrs reiterated a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. SVB Leerink assumed coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. Finally, Piper Sandler upped their price objective on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $81.09.

Henry Schein Stock Performance

Shares of HSIC opened at $73.13 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The business has a 50-day simple moving average of $74.17 and a two-hundred day simple moving average of $72.42. The stock has a market cap of $9.40 billion, a price-to-earnings ratio of 23.22, a PEG ratio of 1.81 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion during the quarter, compared to analysts’ expectations of $3 billion. During the same quarter in the previous year, the company earned $1.21 EPS. The business’s quarterly revenue was down 10.5% compared to the same quarter last year. On average, analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current year.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.